Asuka Pharmaceutical Holdings: Notice regarding achievement of major evaluation items in the LF111 domestic phase III clinical trial

JPX · Apr 11 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.